Dr. Thomas J. Dunn, D.O.
Nephrology (Kidney) (Nephrology Physician)
129 N Brookmoore Dr
Columbus, MS 39705
Who else practices at this address →
Lowndes County is a federal mental health shortage area. About shortage areas
- Medicare participating
At a glance
- Medical school
- Kansas City University of Med & Biosciences, College of Osteo Med (1999)
- Years since graduation
- 27
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 233
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1999Medical school: Kansas City University of Med & Biosciences, College of Osteo Med
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Nephrology Physician primary
MS license 17656
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Bmh-Golden Triangle Columbus, MS
- Baptist Memorial Hospital-Oktibbeha County Starkville, MS
- Winston Medical Center Louisville, MS
- Noxubee General Critical Access Hosp Macon, MS
Medical groups
- Nephrology Associates, PC (5 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 233
- Services billed
- 4,147
- Patients’ average age
- 67
| Service | Times | Patients |
|---|---|---|
| Dialysis services, 4 or more physician visits per month (20 years or older) | 778 | 101 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 205 | 58 |
| Home dialysis services per month (20 years or older) | 121 | 18 |
| Dialysis services, per day, less than full month service (20 years or older) | 113 | 11 |
| Established patient office or other outpatient visit, 30-39 minutes | 92 | 60 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 60 | 39 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 42 | 40 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 38 | 22 |
| New patient office or other outpatient visit, 45-59 minutes | 17 | 17 |
| Established patient office or other outpatient visit, 20-29 minutes | 12 | 11 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Sevelamer Carbonate Other prescribers in Columbus, MS | 356 |
| Velphoro (sucroferric oxyhydroxide) | 106 |
| Auryxia (ferric citrate) | 103 |
| Amlodipine Besylate Other prescribers in Columbus, MS | 77 |
| Carvedilol Other prescribers in Columbus, MS | 57 |
| Hydralazine Hcl Other prescribers in Columbus, MS | 56 |
| Midodrine Hcl Other prescribers in Columbus, MS | 35 |
| Atorvastatin Calcium Other prescribers in Columbus, MS | 35 |
| Furosemide Other prescribers in Columbus, MS | 30 |
| Nifedipine Er (nifedipine) Other prescribers in Columbus, MS | 28 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 2 companies reported 2 payments worth $23.52 in total to this clinician.
| Fresenius USA Marketing, Inc. | $21.86 |
|---|---|
| Travere Therapeutics, Inc. | $1.66 |
| Food and Beverage | $21.86 |
|---|---|
| Education | $1.66 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Travere Therapeutics, Inc. Jul 25, 2025 | Education Filspari · Kidney Disease · in-kind | $1.66 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $277,146 in research payments for these studies, mostly to the institutions running them.
- Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
Csl Behring · Recruiting · NCT05485961
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.